Explore the Milestones of Scientific Contribution against Cancer Evolution at Epigenetics and Cancer 2018
The 2nd International Conference on Cancer Genetics & Epigenetics will be held during November 12th-13th, 2018 at Tokyo, Japan. Theme: “The Milestones of Scientific Contribution Against Cancer Evolution: Research, Trials, Patient Advocacy & Nursing”.
(IINews) - Conference Series LLC Ltd invites all the participants from all over the world to attend 2nd International Conference on Cancer Genetics & Epigenetics during November 12th-13th, 2018 in Tokyo, Japan. It includes Keynote Presentations, Poster Presentations, E-poster, Oral talks, Workshop, and Exhibitions.
The attendees can find-
•Exclusive Sessions and Panel discussions on latest innovations in Epigenetics, Cancer Treatment, Cancer Surgery, Clinical Trials, Nursing Research & Patient Advocacy
•Lectures by active practitioners
•Keynote forums by Prominent Surgeons
•Open Innovation Challenges
•Poster presentations by Young Researchers
•Global Networking sessions with 50+ Countries
•Novel techniques to benefit your research
•Best platform for Global business and Networking opportunities
•Meet the editors of referred journals, Society and Association members across the Globe
•Excellent platform to showcase the latest products and formulations in Cosmetic Industry
The scientific program will focus on current advances in the research and leading strategies in cancer treatment with a theme “The Milestones of Scientific Contribution against Cancer Evolution: Research, Trials, Patient Advocacy & Nursing”. The conference highlights are: Cancer Evolution, Cancer Research and Trials, Cancer Surgery, Cancer Genomics and Epigenomics, Epigenetics and Cancer, Epigenomic Effects of Environmental Exposures, Biomarkers, Epigenetic Biomarkers in Cancer, Nursing and Patient Advocacy, Nursing education and research, Oncology nursing and many more.
The conference will feature keynote presentations by top professionals as well as renowned experts in the field from all around the globe. In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for pharmacy educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Cancer genetics and Epigenetics.
Epigenetics and Cancer 2018 is a leading platform and must attend event for Professors, Physicians, Pharmacists, Scientists, Clinical Fellows, Research and Diagnostic Laboratories. It provides an interactive forum with thought leaders presenting on Cancer Evolution, Research and Trials, Surgery, Epigenetics, Biomarkers, Nursing Practices and Patient Advocacy and application in Pharmaceutical and Life Sciences Industry.
The conference focuses on the wider aspect of the scientific contribution to showcase the new scientific and technical advances in comparison to the ancient theories. Your perspective and our visualization together will set a platform for the exchange of ideas towards contribution to advanced innovation.
WHO SHOULD ATTEND?
1.Scientists
2.Professors
3.Doctors
4.Students
5.Nurses
6.Patient Advocates
7.Business delegates
Conference Insight:
•300+ Participation (70 Industry: 30 Academia)
•5+ Keynote Speakers
•50+ Plenary Speakers
•20+ Exhibitors
•14 Innovative Educational Sessions
•5+ Workshops
•B2B Meetings
The event is exclusively supported Epigenetics, Oncology Societies and Associations. Conference also offers Exhibition and Sponsorship opportunity for the interested organizations.
If you would like to know more information about this conference, to book a slot, Sponsorship and Exhibit sales information,
Please Contact: Evangeline White
Tel.: +1650-889-4686
Email: worldepigenetics(at)oncologymeet.com | worldepigenetics(at)cancersummit.org
Or
Visit: https://epigeneticsconference.conferenceseries.com/
Themen in diesem Fachartikel:
Unternehmensinformation / Kurzprofil:
Conference Series LLC LTD is an open resource platform that conducts 3000+ global events including International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and Science Congresses in all the major scientific disciplines, including Clinical, Medical, pharmaceutical, Engineering, Technology, Business Management and Life Sciences across America, Europe, The Middle East, and Asia Pacific. It is reaching over 25 million researchers, scholars, students, professionals and corporate entities all over the globe.
World renowned scientists, Noble laureates and scholars in their respective fields grace our events as keynote speakers, panel experts, and organizing committee members. Our speakers gain global visibility and recognition as we take them straight to the audience through live streaming that broadcasts your spoken words all over the globe instantaneously.
With its world class state of innovation and information knowhow, our conferences facilitate knowledge dissemination through round table discussions, debates, workshops and, poster presentations. Corporate entities, academic and research institutions benefit from the dignitaries of world class, including CEOs and policy makers and can ripe the benefits through B2B meetings, networking, product launching and promotion.
We encourage our authors and conference participants through research and travel grants, young research awards and provide assistance in career development and research guidance through 1000+ collaborations with NGOs, scientific and academic agencies, institutions that have signed MoU with us.
Programme Co-Ordinator
Conferenceseries llc Ltd
47 Churchfield Road
London, W3 6AY
Datum: 03.05.2018 - 06:56 Uhr
Sprache: Deutsch
News-ID 1606898
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner: Evangeline White
Stadt:
Churchfield
Telefon: 6508894686
Kategorie:
Vermischtes
Anmerkungen:
Dieser Fachartikel wurde bisher 43 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Explore the Milestones of Scientific Contribution against Cancer Evolution at Epigenetics and Cancer 2018
"
steht unter der journalistisch-redaktionellen Verantwortung von
Conference Series llc Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).